Barclays PLC Ark Genomic Revolution ETF (De Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Barclays PLC holds 22,000 shares of ARKG stock, worth $541,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,000
Previous 285,108
92.28%
Holding current value
$541,640
Previous $7.3 Million
92.9%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ARKG
# of Institutions
285Shares Held
23.3MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$89.3 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$85.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$68.7 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$68.5 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$40.8 Million0.02% of portfolio